Press Releases Stay on top of the latest news from Poseida Therapeutics. Learn about our leading-edge cell and gene therapy programs, from new discoveries to clinical trials, and get the most recent investor news. IR Sub Menu Investors & Media Corporate Profile Press Releases Events & Presentations Publications Year None2021202020192018201720162015 Poseida Therapeutics Announces Series A Financing 12/16/2015 Poseida Therapeutics, Inc. Announces Worldwide License Agreement With Janssen to Apply Centyrin Technology in the Development of Chimeric Antigen Receptor (CAR) Therapies 08/11/2015 Poseida Therapeutics, Inc., Expands Board of Directors 08/05/2015 Poseida Therapeutics to Participate in Jefferies 2015 Healthcare Conference 06/01/2015 Poseida Therapeutics, Inc., Expands Into JLABS to Foster Research Collaboration With Janssen for Development of Allogeneic CAR-T Therapies 06/01/2015 Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Current page 8 Displaying 71 - 75 of 75
Year None2021202020192018201720162015 Poseida Therapeutics Announces Series A Financing 12/16/2015 Poseida Therapeutics, Inc. Announces Worldwide License Agreement With Janssen to Apply Centyrin Technology in the Development of Chimeric Antigen Receptor (CAR) Therapies 08/11/2015 Poseida Therapeutics, Inc., Expands Board of Directors 08/05/2015 Poseida Therapeutics to Participate in Jefferies 2015 Healthcare Conference 06/01/2015 Poseida Therapeutics, Inc., Expands Into JLABS to Foster Research Collaboration With Janssen for Development of Allogeneic CAR-T Therapies 06/01/2015 Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Current page 8 Displaying 71 - 75 of 75
Poseida Therapeutics, Inc. Announces Worldwide License Agreement With Janssen to Apply Centyrin Technology in the Development of Chimeric Antigen Receptor (CAR) Therapies 08/11/2015
Poseida Therapeutics, Inc., Expands Into JLABS to Foster Research Collaboration With Janssen for Development of Allogeneic CAR-T Therapies 06/01/2015